Research Topics
Genomes and GenesSpecies | E BruckertSummaryCountry: France Publications
| Collaborators
|
Detail Information
Publications
[Therapeutic and pleiotropic effects of statins in primary and secondary prevention of atherosclerosis]E Bruckert
Service d Endocrinologie Métabolisme, Unité de prévention des maladies cardiovasculaires, Hopital Pitie Salpetriere, 47, 83 bld de l hôpital 75651 Paris
Bull Acad Natl Med 185:49-60; discussion 60-2. 2001..Finally, translating results of recent trials in clinical practice remains a challenge for treating physicians who face poor compliance and difficulties in implementing diet in patients...
Educational level has a major impact on the representations of cholesterol: a study in 1579 hypercholesterolemic patientsSilla M Consoli
Department of Consultation Liaison Psychiatry, European Georges Pompidou Hospital, Assistance Publique Hospitaux de Paris, Paris, France
Prev Med 38:323-9. 2004..To determine the specific features of representations of cholesterol and hypercholesterolemia according to the educational level (EL) and gender among hypercholesterolemic (HC) subjects...
Carotid atherosclerosis is not related to past tuberculosis in hypercholesterolemic patientsPhilippe Giral
Unités de Prévention Cardiovasculaire, Service d Endocrinologie Métabolisme, Groupe Hospitalier Pitie Salpetriere, France
Atherosclerosis 190:150-5. 2007..Furthermore immunization with recombinant heat shock protein-65-rich mycobacterium tuberculosis increased atherogenesis in hypercholesterolemic animal models...
[Hyperlipidemias: new data and new concepts]E Bruckert
Service d Endocrinologie Métabolisme, Hopital Pitie Salpetriere, 83, Boulevard de l Hopital, F75651 Paris
Presse Med 30:177-81. 2001..IMPORTANCE OF DIET: Finally, translating results of recent trials in clinical practice remains a challenge for treating physicians who face poor compliance and difficulties in implementing diet in patients...
New lipid-modifying therapiesEric Bruckert
Department of Endocrinology and Metabolism, Assitance Publique Hôpitaux de Paris, University Hôp ital Pitie Salpêtrière, Paris, France
Expert Opin Investig Drugs 12:325-35. 2003..In addition, advances in our understanding of the pathophysiology of dyslipidaemia have enabled other novel therapeutic targets to be identified and studies with experimental drugs underscore the potential of these approaches...
Components of the fibrinolytic system are differently altered in moderate and severe hypothyroidismR Chadarevian
Service d Endocrinologie Métabolisme, Hopital Pitie Salpetriere, 75013 Paris, France
J Clin Endocrinol Metab 86:732-7. 2001..Subjects with severe hypothyroidism have a tendency toward increased fibrinolytic activity, and these modifications may participate to the bleeding tendency observed in such patients...
Low free-thyroxine levels are a risk factor for subclinical atherosclerosis in euthyroid hyperlipidemic patientsE Bruckert
Service d Endocrinologie Métabolisme, Hopital Pitie Salpetriere, Paris, France
J Cardiovasc Risk 6:327-31. 1999..Patients displaying overt and subclinical hypothyroidism have more cardiovascular risk factors. Consequently, they are more likely to develop atherosclerosis and cardiovascular diseases...
Comparison of efficacy and safety assessment of fluvastatin in patients <65 years versus > or =65 years of ageEric Bruckert
Endocrinology Department, Hopital Pitie Salpetriere, Assistance Publique Hopitaux de Paris, Paris, France
Am J Cardiol 96:1142-8. 2005..Furthermore, this pooled analysis supports the use of fluvastatin to lower cholesterol levels in older high-risk patients...
Perspectives in cholesterol-lowering therapy: the role of ezetimibe, a new selective inhibitor of intestinal cholesterol absorptionEric Bruckert
, AP-HP, , Paris, France
Circulation 107:3124-8. 2003
Mild to moderate muscular symptoms with high-dosage statin therapy in hyperlipidemic patients--the PRIMO studyEric Bruckert
Department of Endocrinology, Hopital de la Pitie Salpetriere, Assistance Publique Hôpitaux de Paris 83 Bd de L Hôpital, 75 013, Paris, France
Cardiovasc Drugs Ther 19:403-14. 2005..To characterize the risk factors, rate of occurrence, onset, nature and impact of mild to moderate muscular symptoms with high-dosage HMG-CoA reductase inhibitor (statin) therapy in general practice...
High prevalence of low HDL-cholesterol in a pan-European survey of 8545 dyslipidaemic patientsEric Bruckert
Groupe Hospitalier Pitie Salpetriere, Paris, France
Curr Med Res Opin 21:1927-34. 2005..The main objective was to obtain a reliable estimation of the prevalence of low HDL (< 1.03 mmol/L [< 40 mg/dL] in men; < 1.29 mmol/L [< 50 mg/dL] in women)...
Blood lipid and lipoprotein levels: relationships with educational level and region of residence in the French SU.VI.MAX studyE Bruckert
Service d Endocrinologie Métabolisme, AP HP, Hopital Pitie Salpetriere, 83 Boulevard de l hopital, 75013 Paris, France
Prev Med 40:803-11. 2005....
New advances in lipid-modifying therapies for reducing cardiovascular riskEric Bruckert
Service d Endocrinologie Métabolisme, CHU Pitie Salpetriere, Assistance Publique, Hopitaux de Paris, Paris, France
Cardiology 97:59-66. 2002..Studies with experimental drugs have already demonstrated the potential of these approaches...
Relationship between triglycerides and factor VIIc and plasminogen activator inhibitor type-1: lack of threshold valueR Chadarevian
Department of Endocrinology, Hopital Pitie Salpetriere, Paris, France
Thromb Res 96:175-82. 1999..We conclude that the relationships between triglyceride levels and FVIIc, as well as PAI-1, are continuous without threshold value of triglycerides...
Cysteine is a cardiovascular risk factor in hyperlipidemic patientsN Jacob
Laboratory of Biochemistry C, Groupe Hospitalier Pitie Salpetriere, Paris, France
Atherosclerosis 146:53-9. 1999..89). Adjusted odds ratios were found to be weaker when homocysteine tertiles were compared. Our data suggest that plasma total cysteine is a risk factor for atherosclerosis in hyperlipidemic patients...
Elevated levels of interleukin 6 are reduced in serum and subcutaneous adipose tissue of obese women after weight lossJ P Bastard
Service de Biochimie, Hopital de la Salpetriere, Paris, France
J Clin Endocrinol Metab 85:3338-42. 2000..The reduced production and serum concentrations after weight loss could play a role in the improved sensitivity to insulin observed in these patients...
Elevated C-reactive protein constitutes an independent predictor of advanced carotid plaques in dyslipidemic subjectsR Blackburn
, Paris, France
Arterioscler Thromb Vasc Biol 21:1962-8. 2001..Body mass index and other markers of the metabolic syndrome (HDL cholesterol, triglycerides, diabetes, and high blood pressure) are significant determinants of CRP levels in this population...
Subcutaneous adipose tissue expression of plasminogen activator inhibitor-1 gene during very low calorie diet in obese subjectsJ P Bastard
Service de Biochimie, Hopital de la Salpetriere, AP HP, Paris
Int J Obes Relat Metab Disord 24:70-4. 2000..To determine whether changes in subcutaneous adipose tissue plasminogen activator inhibitor-1 (PAI-1) expression influence plasma PAI-1 level during weight loss in obese humans...
Relationship between thyroid hormones and fibrinogen levelsR Chadarevian
Hopital Pitie Salpetriere, Paris, France
Blood Coagul Fibrinolysis 10:481-6. 1999..These results are consistent with our previous findings of a tendency to a more coagulable state in patients with normal-low FT4 levels compared with those with normal-high FT4 levels...
Homocysteine and lipid lowering agents. A comparison between atorvastatin and fenofibrate in patients with mixed hyperlipidemiaP Giral
Service d Endocrinologie Métabolisme, Centre de Détection et de Prévention de l Athérosclérose, Groupe Hospitalier Pitié, Salpetriere, 47 83 boulevard de l Hopital, 75651 Cedex 13, Paris, France
Atherosclerosis 154:421-7. 2001..We compared the effect of a statin and a fibrate (atorvastatin and fenofibrate) on plasma levels of homocysteine and other thiol compounds in hyperlipidemic patients...
Usefulness in predicting coronary artery disease by ultrasonic evaluation of the carotid arteries in asymptomatic hypercholesterolemic patients with positive exercise stress testsP Giral
Service d Endocrinologie Métabolisme, Groupe Hospitalier Pitie Salpetriere, Universite Pierre et Marie Curie, Paris, France
Am J Cardiol 84:14-7. 1999..We conclude that the combination of clinical, electrical, and echographic data facilitates cost-effective noninvasive detection of CAD in asymptomatic hypercholesterolemic patients...
Smaller LDL particle size in women with polycystic ovary syndrome compared to controlsS Dejager
Service d endocrinologie, La Pitié Salpêtrière, Paris, France
Clin Endocrinol (Oxf) 54:455-62. 2001..We aimed to examine LDL size variation in relation to androgens and other risk factors in women with PCOS...
Effect of levothyroxine replacement therapy on coagulation and fibrinolysis in severe hypothyroidismR Chadarevian
, , Paris, France
J Endocrinol Invest 28:398-404. 2005..However, the clinical consequences of the transient decrease of the fibrinolytic activity during the course of TSH normalization need further studies...
Variations in plasma soluble tumour necrosis factor receptors after diet-induced weight loss in obesityJ P Bastard
Service de Biochimie, H pital de la Salpêtrière, Paris, France
Diabetes Obes Metab 2:323-5. 2000..5 kg), this result supports the emerging concept that adipose tissue can produce significant amounts of sTNFR-I and that this production can be modified by weight loss in human obesity...
Relationship between alcohol intake, health and social status and cardiovascular risk factors in the Urban Paris-Ile-de-France Cohort: is the cardioprotective action of alcohol a myth?B Hansel
Service d Endocrinologie Métabolisme, AP HP, Hopital de la Pitie, Paris, France
Eur J Clin Nutr 64:561-8. 2010..The aim of our study was to evaluate potential confounders, which may contribute to putative cardioprotection by alcohol...
[Is regression of atherosclerosis possible?]D Thomas
Service de cardiologie, Groupe Hospitalier Pitie Salpetriere, Paris
Arch Mal Coeur Vaiss 85:47-57. 1992..The clinical repercussion of studies of prevention involving a single lipid factor is probably partially due to the reduction in progression and anatomical regression of the atherosclerotic plaque.(ABSTRACT TRUNCATED AT 250 WORDS)..
[Prevalence of sleep apnea in men with metabolic syndrome and controlled hypertension]B Hansel
Service d endocrinologie métabolisme et de prévention cardiovasculaire, Hopital de la Pitie Salpetriere, Paris
Arch Mal Coeur Vaiss 100:637-41. 2007..The reliability of this test to identify SAS has not been studied in patients with MS...
Changes in lipoprotein(a) levels and hormonal correlations during a weight reduction programD N Kiortsis
Department of Endocrinology, , Paris, France
Nutr Metab Cardiovasc Dis 11:153-7. 2001..This effect seems to be independent of the hormonal changes observed during weight loss...
Plant sterol-enriched margarine lowers plasma LDL in hyperlipidemic subjects with low cholesterol intake: effect of fibrate treatmentF Nigon
, , Paris, France
Clin Chem Lab Med 39:634-40. 2001..We conclude that phytosterol-enriched spread is a useful adjunctive therapy for hypercholesterolemic patients...
[Lipid profile and cardiovascular risk in patients with rheumatoid arthritis: Effect of the disease and of drug therapy]B Hansel
Service d endocrinologie métabolisme et de prévention cardiovasculaire, Hopital de la Pitie Salpetriere, 47 83, Boulevard de l Hopital, 75013 Paris, France
Ann Endocrinol (Paris) 71:257-63. 2010..The influence of recently developed compounds, anti-CD20, CTLA-4 Ig or anti-IL6 is not well documented. Anti-IL6 seem to increase total and LDL-cholesterol; however these changes are associated with an improvement in the TC/HDL-C ratio...
[Influence of hospitalisation on drug prescription in arterial hypertension and chronic conditions]P Hindlet
Service de Pharmacie, Groupe Hospitalier Pitie Salpetriere, Assistance Publique Hopitaux de Paris, 75013 Paris, France
Ann Cardiol Angeiol (Paris) 61:224-8. 2012..To evaluate the influence of hospitalization on drug prescription in chronic conditions...
[Hyperlipidemia in patients over 60 years old]E Bruckert
Service d Endocrinologie Métabolisme, Hopital Pitie Salpetriere, Lyon
Arch Mal Coeur Vaiss 85:79-82. 1992..Treatment should therefore be reserved for sever forms of hyperlipidemia, taking into consideration the life expectancy of the individual...
Serum levels of adhesion molecules ICAM-1 and VCAM-1 and tissue inhibitor of metalloproteinases, TIMP-1, are elevated in patients with autoimmune thyroid disorders: relevance to vascular inflammationC Jublanc
Service d Endocrinologie Métabolisme, Groupe Hospitalier Pitie Salpetriere, Assistance Publique Hopitaux de Paris AP HP, Paris, France
Nutr Metab Cardiovasc Dis 21:817-22. 2011..Whether these biological abnormalities translate into increase intima remodelling and atherosclerosis remains to be studied...
Relationship of circulating C-reactive protein levels to thyroid status and cardiovascular risk in hyperlipidemic euthyroid subjects: low free thyroxine is associated with elevated hsCRPC Jublanc
Department of Endocrinology, group hospitalier La Pitié Salpêtrière, Hopital Pitie Salpetriere, AP HP, 47 83 Boulevard de l Hôpital 75651, Paris Cedex 13, France
Atherosclerosis 172:7-11. 2004....
[New non-lipidic biological markers of atherosclerosis]J L Beaudeux
Service de Biochimie C, , , AP-HP, 47-83, , 75651 Paris Cedex 13, France
Ann Med Interne (Paris) 152:169-79. 2001..This review presents recent data that could contribute to use of these markers for the diagnosis and the evolution of atherosclerosis. in clinical practice...
[Subclinical hypothyroidism: a cardiovascular risk factor?]F Cohen-Aubart
Service d Endocrinologie Métabolisme, Groupe Hospitalier La Pitié Salpêtrière, 47 83, Boulevard de l Hopital, 75013 Paris
Arch Mal Coeur Vaiss 100:213-6. 2007..The authors review the epidemiological evidence and the mechanisms underlying the association between infraclinical hypothyroidism and cardiovascular risk and the therapeutic implications of this association...
[Endocrine disease in adrenoleukodystrophy]S Girard
, , 83, , 75651 Paris Cedex 13
Ann Med Interne (Paris) 152:15-26. 2001..Gene therapy is a promising perspective. Lovastatin and 4-phenlbutyrate have recently been shown to normalize plasma VLCFA levels. Their therapeutic efficacy must be assessed in a randomized trial...
A comprehensive endocrine description of Kennedy's disease revealing androgen insensitivity linked to CAG repeat lengthS Dejager
Department of Endocrinology, Hopital de la Pitie Salpetriere, Assistance Publique Hopitaux de Paris, France
J Clin Endocrinol Metab 87:3893-901. 2002..In clinical practice, KD patients are often misdiagnosed as having amyotrophic lateral sclerosis. Careful examination of the endocrine component could avoid such a deleterious misdiagnosis...
[Adherence to national guidelines for lipid management in a department of endocrinology]F Chiche
Service d Endocrinologie Métabolisme, Hopital de la Pitie Salpetriere, 75013 Paris, France
Ann Endocrinol (Paris) 70:119-25. 2009..The objective of this study was to assess clinical practices based on these recommendations in a department of endocrinology specialized in the management of dyslipidemic patients...
The THEMA study: a sociodemographic survey of hypercholesterolaemic individualsT Fournier
Universite de Toulouse, CERTOP CNRS, UTM, Toulouse, France
J Hum Nutr Diet 24:572-81. 2011..The present study aimed to gather relevant information and investigate social determinants of dietary compliance...
Systemic low-grade inflammation is related to both circulating and adipose tissue TNFalpha, leptin and IL-6 levels in obese womenM Maachi
Service de Biochimie et Hormonologie, , AP-HP, France
Int J Obes Relat Metab Disord 28:993-7. 2004....
Are physicians able to identify high-risk abdominally obese individuals? An analysis from the pan-European Survey of HDL-cholesterolM Baccara-Dinet
CardioMetabolic Care, Merck Santé, Paris, France
Curr Med Res Opin 23:2005-8. 2007..The objective of this study was to explore physicians' perceptions of the obesity status of their patients in comparison with objective measurements of generalised or abdominal obesity...
[Matrix metalloproteinases and atherosclerosis. Therapeutic aspects]J L Beaudeux
Service de Biochimie C, Group Hospitalier Pitie Salpetriere, AP HP, 47 83 boulevard de l Hopital, 75651 Paris Cedex 13
Ann Biol Clin (Paris) 61:147-58. 2003..This review highlights the structures of MMPs and their physiological inhibitors, the Tissue Inhibitors of MMPs (TIMPs), and describes the current developments in pharmacological MMP inhibition...
Pituitary carcinoma: report of an exceptional case and review of the literatureC Pichard
Department of Endocrinology, Groupe Hospitalier La Pitié Salpêtrière, Paris, France
J Endocrinol Invest 25:65-72. 2002..In the discussion, we stress the need to detect these very aggressive tumors as early as possible and identify treatments to improve the dramatic course of these carcinomas...
[Contribution of NMR to the assessment of dyslipidemia-related cardiovascular risk]D Bonnefont-Rousselot
Laboratoire de biochimie métabolique et clinique EA 3617, Faculte des Sciences Pharmaceutiques et Biologiques, Universite Paris Descartes, Paris, France
Ann Pharm Fr 66:123-8. 2008....
[New insights and perspectives in the management of dyslipidemia]F Cohen Aubart
Services de Pharmacologie, Hopital de la Pitie Salpetriere, APHP, 47 83, Boulevard de l Hopital, 75013 Paris, France
Rev Med Interne 28:537-44. 2007..Flushing may occur in 80% of treated patients. Two CETP inhibitors have shown therapeutical efficacy to raise HDL cholesterol, but clinical benefit remains uncertain...
Screening for liver disease using non-invasive biomarkers (FibroTest, SteatoTest and NashTest) in patients with hyperlipidaemiaV Ratziu
APHP Hépatologie GHPS, Paris, France
Aliment Pharmacol Ther 25:207-18. 2007..It is impossible to perform liver biopsy in such a large number of hyperlipidaemic patients to identify patients with advanced liver fibrosis or with steatohepatitis (non-alcoholic steatohepatitis, NASH)...
[Graves' disease and autoimmune thrombocytopenic purpura: distinct outcomes of the two diseases]F Cohen Aubart
Service d Endocrinologie Métabolisme, Groupe Hospitalier de la Pitié Salpêtrière, APHP, 47 83, Boulevard de l Hopital, 75013 Paris, France
Ann Endocrinol (Paris) 68:55-7. 2007..Thus, the hypothesis of cross-reaction between antithyroid antibodies and platelet epitopes, which has been proposed to explain the association, seems unlikely...
Adrenal insufficiency after adrenal hemorrhageC Jublanc
Department of Endocrinology, Groupe Hospitalier La Pitié Salpêtrière, Paris, France
J Endocrinol Invest 27:67-9. 2004..We report a case of AAH following a sepsis, resulting in persistant adrenal insufficiency contrasting with the radiologic normalisation of the adrenals on computed tomography (CT) scan imaging...
A constellation of cardiovascular risk factors is associated with hepatic enzyme elevation in hyperlipidemic patientsE Bruckert
Department of Endocrinology, INSERM U 551 and IFR Caeur Muscle Vaisseau, Paris, France
Metabolism 51:1071-6. 2002..Because these abnormalities may not only be reversible but also associated with a poor prognosis, further studies are needed to identify those dyslipidemic patients who are at risk for the development of severe hepatic tissue damage...
[Cardiovascular complications in minor endogenous hypertriglyceridemia. Study of 235 cases]E Bruckert
, , Paris
Arch Mal Coeur Vaiss 80:1587-92. 1987..This study emphasizes the point that metabolically as well as clinically pure hypertriglyceridaemia is a very heterogeneous metabolic abnormality, as shown by its repercussions on the vascular system...
Low HDL-cholesterol is common in European Type 2 diabetic patients receiving treatment for dyslipidaemia: data from a pan-European surveyE Bruckert
Groupe Hospitalier Pitie Salpetriere, Paris, France
Diabet Med 24:388-91. 2007..To measure the prevalence of low high-density lipoprotein (HDL)-cholesterol (men < 1.03 mmol/l; women < 1.29 mmol/l) in European Type 2 diabetic patients receiving treatment for dyslipidaemia...
[Phytosterols and atherosclerosis]B Hansel
Service d endocrinologie et de prévention cardiovasculaire, Hopital de la Pitie Salpetriere, 47 83, Boulevard de l Hopital, 75013 Paris, France
Rev Med Interne 32:124-9. 2011..However, further studies are highly encouraged to examine the CV benefit of PS enriched food...
[Role of triglycerides in cardiovascular diseases]E Bruckert
, , Paris
Arch Mal Coeur Vaiss 85:29-35. 1992..Despite these epidemiological data, the measurement of serum triglyceride levels remains important in patients with hyperlipidemia...
HDL-c is a powerful lipid predictor of cardiovascular diseasesE Bruckert
Institute of Endocrinology and Prevention of Cardiovascular disease, Pavillon Benjamin Delessert, Hôpital de Pitié Salpêtrière, Assistance Publique Hopitaux de Paris, Paris, France
Int J Clin Pract 61:1905-13. 2007..Patients with very low HDL-c need a thorough evaluation by specialist physicians. Statins are associated with a modest increase of HDL-c (5%) while fibrates and nicotinic acid increase HDL-c by 10% and 20% respectively...
[Hepatotoxicity of a synthetic cortisol antagonist: OP'DDD (mitotane)]O Neuman
, , , 75013 Paris, France
Therapie 56:793-7. 2001..We conclude that transaminase increase is encountered in the vast majority of patients treated with Mitotane. Levels at which the drug should be withdrawn remain to be established...
[The growth hormone/insulin-like growth factor axis. What is its role in the atherosclerotic process?]T B Twickler
INSERM Unité 551, Hopital Pitie Salpetriere, Paris
Presse Med 32:1238-43. 2003..Study of the GH/IGF axis activity and of its correlation with atherosclerosis opens new perspectives in the understanding of the role of this axis in cardiovascular diseases...
Effects of octreotide on lipid metabolism in acromegalyR Cohen
Department of Internal Medicine and Endocrinology, , Paris, France
Horm Metab Res 24:397-400. 1992..In conclusion, the administration of octreotide over a three month period to acromegalic patients is associated with a decrease in TG levels...
APOE: a potential marker of disease progression in ALSL Lacomblez
, Service de Pharmacologie, AP-HP, , Paris, France
Neurology 58:1112-4. 2002..In contrast, APOE plasma levels were correlated with both rate of deterioration and survival time and appeared to be an important risk factor for decreased survival time with a relative risk of 0.647 (95% CI: 0.465 to 0.901; p = 0.01)...
Elevated gamma-glutamyltransferase activity and perturbed thiol profile are associated with features of metabolic syndromePhilippe Giral
Unités de Prévention Cardiovasculaire, Groupe Hospitalier Pitié Salpétrière Université Pierre et Marie Curie, 75651 Paris Cedex 13, France
Arterioscler Thromb Vasc Biol 28:587-93. 2008..We compared the circulating thiol profile in a cohort of patients displaying atherogenic dyslipidemia with and without MS...
One third of the variability in HDL-cholesterol level in a large dyslipidaemic population is predicted by age, sex and triglyceridaemia: The Paris La Pitié StudyBoris Hansel
Service d Endocrinologie Métabolisme AP HP, Hopital de la Pitie, Paris, France
Curr Med Res Opin 22:1149-60. 2006....
Serum matrix metalloproteinase-3 and tissue inhibitor of metalloproteinases-1 as potential markers of carotid atherosclerosis in infraclinical hyperlipidemiaJean Louis Beaudeux
Department of Clinical Biochemistry, Groupe Hospitalier Pitie Salpetriere, 47 83 boulevard de l Hopital, Paris Cedex 13 F75651, France
Atherosclerosis 169:139-46. 2003..Such elevations might reflect enhanced vascular matrix remodeling, a key feature of the progression of atherosclerotic disease...
Effect of low-fat, fermented milk enriched with plant sterols on serum lipid profile and oxidative stress in moderate hypercholesterolemiaBoris Hansel
Service d Endocrinologie Métabolisme, AP HP, Hopital de la Pitie, Paris, France
Am J Clin Nutr 86:790-6. 2007..Plant sterol (PS)-enriched foods have been shown to reduce plasma LDL-cholesterol concentrations. In most studies, however, PSs were incorporated into food products of high fat content...
Serum plasma pregnancy-associated protein A: a potential marker of echogenic carotid atherosclerotic plaques in asymptomatic hyperlipidemic subjects at high cardiovascular riskJean Louis Beaudeux
Department of Clinical Biochemistry, the National Institute for Health, Paris, France
Arterioscler Thromb Vasc Biol 23:e7-10. 2003..We evaluated serum PAPP-A levels as a marker of the premature development of atherosclerosis in hyperlipidemic subjects at elevated cardiovascular risk...
[Factors associated with the opinion of hypercholesterolemic patients on the duration of their treatment. Results of the FRACTION study]Silla M Consoli
Service de psychologie clinique et psychiatrie de liaison, Hopital Europeen Georges Pompidou, 20, rue Leblanc 75908 Paris
Presse Med 31:1302-8. 2002..The patients' opinion concerning the severity and evolution of their health problem, as well as the use and duration of their treatment, are, in this context, essential...
Efficacy and safety of ezetimibe coadministered with atorvastatin or simvastatin in patients with homozygous familial hypercholesterolemiaClaude Gagne
CHUL du CHUQ, Ste Foy, Quebec, Canada
Circulation 105:2469-75. 2002..Ezetimibe provides a new, complementary pharmacological approach for this high-risk population...
Adipose tissue IL-6 content correlates with resistance to insulin activation of glucose uptake both in vivo and in vitroJean Philippe Bastard
Service de Biochimie et Hormonologie, Hôpital Tenon Rothschild, Assistance Publique Hopitaux de Paris AP HP, 75020 Paris, France
J Clin Endocrinol Metab 87:2084-9. 2002..In conclusion, increased IL-6 production by sc adipose cells might participate to the insulin-resistant state observed in human obesity...
[Ten-year morbidity and mortality in a cohort of dyslipidemic patients seen at a hospital endocrinology department]Valérie Carreau
Service d Endocrinologie Métabolisme, AP HP, Groupe Hospitalier Pitie Salpetriere, F 75651 Paris Cedex 13, France
Presse Med 37:385-94. 2008....
Hypothyroidism and cardiovascular disease: role of new risk factors and coagulation parametersChristel Jublanc
, , , Paris, France
Semin Vasc Med 4:145-51. 2004....
Patients' and physicians' perceptions and experience of hypercholesterolaemia: a qualitative studyIsabelle Durack-Bown
Unit for the Prevention of Cardiovascular Disease, , Paris, France
Br J Gen Pract 53:851-7. 2003..This analysis helps to identify appropriate educational objectives and methods for patients at risk of cardiovascular disease, and develop a structured educational programme...
Elevated serum levels of proinflammatory cytokines and biomarkers of matrix remodeling in never-treated patients with familial hypercholesterolemiaMariame El Messal
Faculte des Sciences Ain Chock, Universite Hassan II Ain Chock, Casablanca, Morocco
Clin Chim Acta 366:185-9. 2006..Although FH is monogenic, wide variation occurs in the onset and severity of atherosclerosis in these patients...
Intake of added oils and fats among middle-aged French adults: relationships with educational level and region of residenceSebastien Czernichow
Department of Nutrition, Hotel Dieu Hospital, University Pierre et Marie Curie, Paris, France
J Am Diet Assoc 105:1889-94. 2005..To describe the relative contribution of 10 created food groups to total fat intake in middle-aged subjects. The relationship of added oil and fat intake with region of residence and educational level was also assessed...
Action of ciprofibrate in type IIb hyperlipoproteinemia: modulation of the atherogenic lipoprotein phenotype and stimulation of high-density lipoprotein-mediated cellular cholesterol effluxMaryse Guerin
Institut National de la Santé et de la Recherche Médicale Unité 551, Dyslipoproteinemia and Atherosclerosis, Hopital de la Pitie, 75651 Paris, France
J Clin Endocrinol Metab 88:3738-46. 2003....
Short-term efficacy and safety of extended-release fluvastatin in a large cohort of elderly patientsEric Bruckert
, Pavillon Benjamin Delessert, Hopital de la Piti, Paris, France
Am J Geriatr Cardiol 12:225-31. 2003..These findings are consistent with data obtained previously in younger recipients of fluvastatin XL 80 mg, and reinforce the safety of fluvastatin in a population at high risk of drug-drug interactions...
Use of an indirect effect model to describe the LDL cholesterol-lowering effect by statins in hypercholesterolaemic patientsDemiana William Faltaos
Pharmacology Department, Pitie Salpetriere University Hospital, Assistance Publique Hopitaux de Paris, Paris 6 University, Paris, France
Fundam Clin Pharmacol 20:321-30. 2006..The pharmacodynamic parameters for the three statins were accurately estimated. The PK/PD model developed successfully predicted the time course of the LDL-lowering effect of statins...
Matrix metalloproteinases, inflammation and atherosclerosis: therapeutic perspectivesJean Louis Beaudeux
Department of Clinical Biochemistry, Groupe Hospitalier Pitie Salpetriere, AP HP, Paris, France
Clin Chem Lab Med 42:121-31. 2004..This review describes the members of the MMP and TIMP families and discusses the structure, function and regulation of MMP activity; finally, pharmacological approaches to MMP inhibition are highlighted...
Blood lipids in brain infarction subtypesPierre Amarenco
Department of Neurology and Stroke Centre, Bichat Hospital, Denis Diderot University, INSERM U 360, Paris, France
Cerebrovasc Dis 22:101-8. 2006..Little is known about the relationship between hypercholesterolaemia and specific aetiological subtypes of brain infarction (BI)...
Rosiglitazone for nonalcoholic steatohepatitis: one-year results of the randomized placebo-controlled Fatty Liver Improvement with Rosiglitazone Therapy (FLIRT) TrialVlad Ratziu
Universite Pierre et Marie Curie Paris VI, Assistance Publique Hopitaux de Paris, Service d Hepatogastroenterologie, Paris, France
Gastroenterology 135:100-10. 2008..Nonalcoholic steatohepatitis (NASH) is a liver disease that complicates insulin-resistant states. This trial tested the efficacy and safety of rosiglitazone, an insulin-sensitizing agent, in patients with NASH...
Acute pancreatitis in a cohort of 129 patients referred for severe hypertriglyceridemiaCelia Lloret Linares
Nutrition, Pitie Salpetriere Hospital, AP HP, Paris, France
Pancreas 37:13-2. 2008....
LDL particle subclasses in hypercholesterolemia. Molecular determinants of reduced lipid hydroperoxide stabilityLaurent Chancharme
, Pavillon Benjamin Delessert, , , 75651 Paris Cedex 13, France
J Lipid Res 43:453-62. 2002..Elevated concentrations of large, CE-rich, light, and intermediate LDL subclasses (LDL1+2, LDL3) in hypercholesterolemia may therefore act as an abundant proatherogenic source of highly unstable LOOH in the arterial wall...
Is serum cystatin-C a reliable marker for metabolic syndrome?Aude Servais
Department of Nephrology, Pitie Salpetriere Hospital, Paris, France
Am J Med 121:426-32. 2008..We measured cystatin values in dyslipidemic patients and looked for correlations between renal function, cystatin, and metabolic syndrome...
Adiponutrin: A new gene regulated by energy balance in human adipose tissueYong Ming Liu
Equipe d Accueil 3502 and Institut National de la Santé et de la Recherche Médicale INSERM Avenir and Department de Nutrition, Paris VI University, Paris, France
J Clin Endocrinol Metab 89:2684-9. 2004..These results indicate that adiponutrin gene expression in humans is highly regulated by changes in energy balance...
A comprehensive description of muscle symptoms associated with lipid-lowering drugsSylvia Franc
Department of Endocrinology, Hopital de la Pitie Salpetriere, Assistance Publique Hopitaux de Paris, 83 bd de l hopital, 75013 Paris, France
Cardiovasc Drugs Ther 17:459-65. 2003..A spectrum of disease from myalgia to rhabdomyolysis exists as classic side-effect of lipid-lowering treatment (LLT). While myopathy has generated considerable interest, mild musculo-skeletal symptoms are poorly assessed...
A new approach to decrease serum cholesterol levelsEric Bruckert
Cardiovasc Drugs Ther 20:157-8. 2006
Renal disease in cardiovascular disorders: an underrecognized problemAlain Baumelou
Department of Nephrology, , Paris, France
Am J Nephrol 25:95-105. 2005..Pilot programs for screening high-risk populations have shown efficacy in detecting renal disease...
Lipoprotein lipase activity and common gene variants in severely hypertriglyceridemic patients with and without diabetesRita Chadarevian
Service d Endocrinologie Métabolisme, Unités de prévention des maladies cardiovasculaires et Institut Fédératif de recherche Coeur Muscle et Vaisseaux, Assistance Publique Hopitaux de Paris, Paris, France
Horm Res 60:61-7. 2003..In severe type IV hypertriglyceridemia (triglyceride levels >10 g/l), it is yet unknown whether lipoprotein lipase (LPL) differs according to the presence or not of diabetes...
Cardiovascular risk and rheumatoid arthritis: clinical practice guidelines based on published evidence and expert opinionThao Pham
Service de Rhumatologie, CHU de la Conception, Marseille, France
Joint Bone Spine 73:379-87. 2006....
Metabolic syndrome features small, apolipoprotein A-I-poor, triglyceride-rich HDL3 particles with defective anti-apoptotic activityJuliana A de Souza
Universite Pierre et Marie Curie Paris 6, Paris F 75013, France
Atherosclerosis 197:84-94. 2008....
Metabolic syndrome is associated with elevated oxidative stress and dysfunctional dense high-density lipoprotein particles displaying impaired antioxidative activityBoris Hansel
Dyslipoproteinemia and Atherosclerosis Research Unit, National Institute for Health and Medical Research, , , 75013 Paris, France
J Clin Endocrinol Metab 89:4963-71. 2004..Induction of selective increase in the circulating concentrations of dense HDL subfractions may represent an innovative therapeutic approach for the attenuation of high cardiovascular risk in MetS...
Cellular SR-BI and ABCA1-mediated cholesterol efflux are gender-specific in healthy subjectsGiovanna Catalano
Institut National de la Sante et de la Recherche Medicale, UMR_S551, Dyslipoproteinemia and Atherosclerosis, Paris, France
J Lipid Res 49:635-43. 2008..72, P < 0.0001), whereas this relationship was not observed in men. In conclusion, HDL-C level may not represent the absolute indicator of the efficiency of the initial step of the reverse cholesterol transport...
Magnitude of HDL cholesterol variation after high-dose atorvastatin is genetically determined at the LDL receptor locus in patients with homozygous familial hypercholesterolemiaAndrei C Sposito
Dyslipoproteinemia and Atherosclerosis Research Unit U 551, National Institute for Health and Medical Research, Paris, France
Arterioscler Thromb Vasc Biol 23:2078-82. 2003..However, some concerns have been made about the effect of atorvastatin on HDL cholesterol levels in these patients...
Prevention campaigns for cardiovascular diseaseEric Bruckert
Lancet 362:1767-8. 2003
Patients with the metabolic syndrome and a disturbed cortisol balance display more microalbuminuriaSarah F Janssen
Department of Cardiology, University Medical Centre UMC Utrecht, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands
Diab Vasc Dis Res 5:54-8. 2008....
[Abdominal obesity: a health threat]Eric Bruckert
Service d Endocrinologie Métabolisme, Hopital Pitie Salpetriere, F 75013 Paris, France
Presse Med 37:1407-14. 2008..New pharmacological strategies might help manage both abdominal obesity and its metabolic consequences...
